{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:04:45Z","timestamp":1785420285581,"version":"3.56.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients on haemodialysis (HD) are at high risk for cardiovascular events, but heart failure and sudden death are more common than atherosclerotic events. The A Study to Evaluate the Use of Rosuvastatinin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events (AURORA) trial was designed to assess the effect of rosuvastatin on myocardial infarction and death from any cardiac cause in 2773 HD patients. We studied predictors of the atherosclerotic cardiovascular events in AURORA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We readjudicated all deaths and presumed myocardial infarctions according to the criteria used in the Study of Heart and Renal Protection (SHARP); these were specifically developed to separate atherosclerotic from non-atherosclerotic cardiovascular events. The readjudicated atherosclerotic end point included the first event of the following: non-fatal myocardial infarction, fatal coronary heart disease, non-fatal and fatal non-haemorrhagic stroke, coronary revascularization procedures and death from ischaemic limb disease. Stepwise Cox regression analysis was used to identify the predictors of such events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a mean follow-up of 3.2 years, 506 patients experienced the new composite atherosclerotic outcome. Age, male sex, prevalent diabetes, prior cardiovascular disease, weekly dialysis duration, baseline albumin [hazard ratio (HR) 0.96; 95% confidence interval (CI) 0.94\u20130.99 per g\/L increase], high-sensitivity C-reactive protein (HR 1.13; 95% CI 1.04\u20131.22 per mg\/L increase) and oxidized low-density lipoprotein (LDL) cholesterol (HR 1.09; 95% CI 1.03\u20131.17 per 10 U\/L increase) were selected as significant predictors in the model. Neither LDL cholesterol nor allocation to placebo\/rosuvastatin therapy predicted the outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Even with the use of strict criteria for end point definition, non-traditional risk factors, but not lipid disturbances, predicted atherosclerotic events in HD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfw360","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T15:06:19Z","timestamp":1475161579000},"page":"102-112","source":"Crossref","is-referenced-by-count":11,"title":["Predictors of atherosclerotic events in patients on haemodialysis:\n                    <i>post hoc<\/i>\n                    analyses from the AURORA study"],"prefix":"10.1093","volume":"33","author":[{"given":"Marit D","family":"Solbu","sequence":"first","affiliation":[{"name":"University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"},{"name":"Section of Nephrology, Division of Internal Medicine, University Hospital of North Norway, Troms\u00f8, Norway"},{"name":"Metabolic and Renal Research Group, UiT The Arctic University of Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Mj\u00f8en","sequence":"additional","affiliation":[{"name":"Department of Nephrology Ullev\u00e5l, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B","family":"Mark","sequence":"additional","affiliation":[{"name":"University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"},{"name":"Queen Elizabeth University Hospital Glasgow, The Renal and Transplant Unit, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallvard","family":"Holdaas","sequence":"additional","affiliation":[{"name":"Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Fellstr\u00f6m","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Uppsala University Hospital, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E","family":"Schmieder","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, University Hospital, Erlangen-N\u00fcrnberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Inserm, Clinical Investigation Centre 1433, Universit\u00e9 de Lorraine and CHU, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Herrington","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G","family":"Jardine","sequence":"additional","affiliation":[{"name":"University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"},{"name":"Queen Elizabeth University Hospital Glasgow, The Renal and Transplant Unit, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"2025102312475374400_gfw360C1","article-title":"2014 USRD Annual Data Report. Epidemiology of kidney disease in the United States","author":"United States Renal Data System","year":"2014"},{"key":"2025102312475374400_gfw360C2","article-title":"UK Renal Registry 17th Annual Report: Chapter 5 Survival and Cause of Death in UK Adult Patients on Renal Replacement Therapy in 2013: National and Centre-specific Analyses","author":"Steenkamp","year":"2014"},{"key":"2025102312475374400_gfw360C3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90\u2009056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"2025102312475374400_gfw360C4","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jacc.2006.07.010","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)","volume":"48","author":"Zipes","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025102312475374400_gfw360C5","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1523-1755.2004.00657.x","article-title":"Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study","volume":"65","author":"Cheung","year":"2004","journal-title":"Kidney Int"},{"key":"2025102312475374400_gfw360C6","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"key":"2025102312475374400_gfw360C7","first-page":"593","article-title":"Declining prevalence of coronary artery disease in incident dialysis patients over the past two decades","volume":"21","author":"Iwasaki","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"2025102312475374400_gfw360C8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2006.11.042","article-title":"Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients","volume":"49","author":"Charytan","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"2025102312475374400_gfw360C9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"2025102312475374400_gfw360C10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"2025102312475374400_gfw360C11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"2025102312475374400_gfw360C12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000106803","article-title":"Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study","volume":"30","author":"Fellstr\u00f6m","year":"2007","journal-title":"Kidney Blood Press Res"},{"key":"2025102312475374400_gfw360C13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000346710","article-title":"Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study","volume":"37","author":"Schneider","year":"2013","journal-title":"Am J Nephrol"},{"key":"2025102312475374400_gfw360C14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation","volume":"286","author":"D'Agostino","year":"2001","journal-title":"J Am Med Assoc"},{"key":"2025102312475374400_gfw360C15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","article-title":"The Framingham predictive instrument in chronic kidney disease","volume":"50","author":"Weiner","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025102312475374400_gfw360C16","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ki.1995.132","article-title":"Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors","volume":"47","author":"Harnett","year":"1995","journal-title":"Kidney Int"},{"key":"2025102312475374400_gfw360C17","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1093\/ndt\/gfr777","article-title":"Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial","volume":"27","author":"Chertow","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312475374400_gfw360C18","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","article-title":"In-center hemodialysis six times per week versus three times per week","volume":"363","author":"Group","year":"2010","journal-title":"N Engl J Med"},{"key":"2025102312475374400_gfw360C19","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcin.2011.05.022","article-title":"Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention","volume":"4","author":"Hanna","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2025102312475374400_gfw360C20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2011.06.012","article-title":"Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"4","author":"Saltzman","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2025102312475374400_gfw360C21","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"de Jager","year":"2009","journal-title":"J Am Med Assoc"},{"key":"2025102312475374400_gfw360C22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2006070795","article-title":"Association between serum lipids and survival in hemodialysis patients and impact of race","volume":"18","author":"Kilpatrick","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2025102312475374400_gfw360C23","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/ndt\/gfn038","article-title":"Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?","volume":"23","author":"Herzog","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312475374400_gfw360C24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2471\/BLT.14.137935","article-title":"Systematic review of statistics on causes of deaths in hospitals: strengthening the evidence for policy-makers","volume":"92","author":"Rampatige","year":"2014","journal-title":"Bull World Health Organ"},{"key":"2025102312475374400_gfw360C25","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"2025102312475374400_gfw360C26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.107.696765","article-title":"Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction","volume":"116","author":"Herzog","year":"2007","journal-title":"Circulation"},{"key":"2025102312475374400_gfw360C27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register","volume":"268","author":"Szummer","year":"2010","journal-title":"J Intern Med"},{"key":"2025102312475374400_gfw360C28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjcard.2011.07.062","article-title":"Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry)","volume":"109","author":"Gurm","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025102312475374400_gfw360C29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/M14-0746","article-title":"Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review","volume":"161","author":"Stacy","year":"2014","journal-title":"Ann Intern Med"},{"key":"2025102312475374400_gfw360C30","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1523-1755.2005.00233.x","article-title":"Modeling the implications of changes in vascular calcification in patients on hemodialysis","volume":"67","author":"Huybrechts","year":"2005","journal-title":"Kidney Int"},{"key":"2025102312475374400_gfw360C31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"2025102312475374400_gfw360C32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312475374400_gfw360C33","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312475374400_gfw360C34","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.2014.419","article-title":"Development and validation of a predictive mortality risk score from a European hemodialysis cohort","volume":"87","author":"Floege","year":"2015","journal-title":"Kidney Int"},{"key":"2025102312475374400_gfw360C35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","article-title":"Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"(Suppl)","key":"2025102312475374400_gfw360C36","doi-asserted-by":"crossref","first-page":"S376","DOI":"10.1194\/jlr.R800087-JLR200","article-title":"The LDL modification hypothesis of atherogenesis: an update","volume":"50","author":"Steinberg","year":"2009","journal-title":"J Lipid Res"},{"key":"2025102312475374400_gfw360C37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/0886022X.2011.641515","article-title":"Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis","volume":"34","author":"Samouilidou","year":"2012","journal-title":"Ren Fail"},{"key":"2025102312475374400_gfw360C38","first-page":"331","article-title":"Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study","volume":"41","author":"Johnson-Davis","year":"2011","journal-title":"Ann Clin Lab Sci"},{"key":"2025102312475374400_gfw360C39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.lfs.2012.12.002","article-title":"Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio\u2014are they real oxidative stress markers in dialyzed patients?","volume":"92","author":"Pawlak","year":"2013","journal-title":"Life Sci"},{"issue":"(Suppl)","key":"2025102312475374400_gfw360C40","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.3346\/jkms.2009.24.S1.S115","article-title":"Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients","volume":"24","author":"An","year":"2009","journal-title":"J Korean Med Sci"},{"key":"2025102312475374400_gfw360C41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3109\/0886022X.2015.1061871","article-title":"Meta-analysis of statin therapy in maintenance dialysis patients","volume":"37","author":"Sun","year":"2015","journal-title":"Ren Fail"},{"key":"2025102312475374400_gfw360C42","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2215\/CJN.09121010","article-title":"Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis","volume":"6","author":"M\u00e4rz","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312475374400_gfw360C43","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.transproceed.2012.03.061","article-title":"Cardiovascular disease in early kidney transplantation: comparison between living and deceased donor recipients","volume":"44","author":"Yazbek","year":"2012","journal-title":"Transplant Proc"},{"key":"2025102312475374400_gfw360C44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1542-4758.2011.00571.x","article-title":"Risk factors for progression of aortic arch calcification in patients on maintenance hemodialysis and peritoneal dialysis","volume":"15","author":"Kim","year":"2011","journal-title":"Hemodial Int"},{"key":"2025102312475374400_gfw360C45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MD.0b013e318256e076","article-title":"Cardiac findings at necropsy in patients with chronic kidney disease maintained on chronic hemodialysis","volume":"91","author":"Roberts","year":"2012","journal-title":"Medicine"},{"key":"2025102312475374400_gfw360C46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1744-9987.2012.01102.x","article-title":"High prevalence of anti-apolipoprotein\/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage","volume":"16","author":"Pruijm","year":"2012","journal-title":"Ther Apher Dial"},{"key":"2025102312475374400_gfw360C47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/sdi.12281","article-title":"Evidence for the prevention and treatment of stroke in dialysis patients","volume":"28","author":"Herrington","year":"2015","journal-title":"Semin Dial"},{"key":"2025102312475374400_gfw360C48","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/STROKEAHA.115.009095","article-title":"Risk factors of ischemic stroke and subsequent outcome in patients receiving hemodialysis","volume":"46","author":"Findlay","year":"2015","journal-title":"Stroke"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/33\/1\/102\/23439039\/gfw360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/33\/1\/102\/23439039\/gfw360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:48:09Z","timestamp":1761238089000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/1\/102\/2327319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,10,17]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfw360","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2016,10,17]]}}}